MEDICUS PHARMA LTD. Earnings Per Share (Basic)
MEDICUS PHARMA LTD. (MDCX) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- MEDICUS PHARMA LTD. earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- MEDICUS PHARMA LTD. earnings per share, basic for the quarter ending 2026-03-31 was -$0.31.
- MEDICUS PHARMA LTD. earnings per share, basic for the quarter ending 2025-12-31 was -$0.81.
- MEDICUS PHARMA LTD. earnings per share, basic for the quarter ending 2025-09-30 was -$1.12.
- MEDICUS PHARMA LTD. earnings per share, basic for fiscal 2025 was -$2.74.
- MEDICUS PHARMA LTD. earnings per share, basic for fiscal 2024 was -$1.16.
- MEDICUS PHARMA LTD. earnings per share, basic for fiscal 2023 was -$1.53.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-12 | -$0.43 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.31 10-Q · filed 2026-05-14 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.02 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$2.46 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.74 10-K · filed 2026-03-25 |
| 2025-09-30 | -$1.12 10-Q · filed 2025-11-14 | -$1.65 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.91 10-Q · filed 2025-11-14 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.43 10-Q · filed 2026-08-12 | -$0.81 10-Q · filed 2026-08-12 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.42 10-Q · filed 2026-05-14 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-05-14 |
| 2024-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.16 10-K · filed 2026-03-25 |
| 2024-09-30 | -$0.24 10-Q · filed 2025-11-14 | -$0.67 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.84 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$0.44 10-Q · filed 2025-08-11 | -$0.66 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$0.21 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.53 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |